AdaptX

AdaptX

AdaptX

AdaptX is a unique Adaptive Clinical Management™ solution

Clinical Workflows

Do you know anyone using AdaptX?

AdaptX is a unique Adaptive Clinical Management™ solution that promises to transform care through AI-driven mission control. It enables clinical leaders to easily leverage real-world data in a self-serve manner to adapt across patients, teams, protocols, workflows, and facilities. With AdaptX, clinicians can rapidly visualize performance, compare approaches, and improve the quality of care while transforming results.

One of the key advantages of AdaptX is its ability to provide financial, clinical, and equity impacts. With the software, clinicians can monitor, evaluate, improve, and manage treatments and workflows across patients, leading to better financial outcomes. The software is designed to go beyond superficial “reporting” and “metrics” to identify best practices, enlist clinicians, measure compliance, and manage real-world performance – enabling you to rapidly improve quality, efficiency, and equity.

Overall, AdaptX empowers clinicians to make data-driven decisions through real-world data analysis. It enables them to rapidly adapt care, transform results, and improve patient outcomes. The software is designed to be flexible and easy to use, and can be leveraged across different facilities, protocols, and workflows. By providing access to critical data and insights, AdaptX is helping healthcare organizations make better decisions that ultimately benefit patients.

AdaptX

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 20, 2024 at 6:56am